Currently holds positions in Aclaris Therapeutics Inc and Idera Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Director | Aclaris Therapeutics Inc | Jan. 7, 2020 - |
President, Chief Executive Officer, Director | Idera Pharmaceuticals Inc | Dec. 1, 2014 - |
Independent Director | Spark Therapeutics Inc | June 1, 2014 - Dec. 17, 2019 |
Independent Director | Vanda Pharmaceuticals Inc | April 21, 2010 - June 1, 2019 |
Chairman of the Board, President, Chief Executive Officer | Shire Viropharma Inc | Dec. 31, 2008 - Jan. 24, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2021-11-24 | 2021-11-24 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
B Purchase |
7,500
+75.0%
12.1991,425 USD |
7,500 +75.0% | 12.19 | 91,425 USD | |
2021-01-12 | 2021-01-12 |
Idera Pharmaceuticals Inc
(IDRA)
|
S Sale |
3,210
-1.5%
4.2013,474 USD |
3,210 -1.5% | 4.20 | 13,474 USD | |
2021-01-11 | 2021-01-05 |
Idera Pharmaceuticals Inc
(IDRA)
|
S Sale |
2,740
-1.3%
3.9110,700 USD |
2,740 -1.3% | 3.91 | 10,700 USD | |
2020-12-22 | 2020-12-22 |
Idera Pharmaceuticals Inc
(IDRA)
|
PS Planned sale |
37,169
-14.8%
4.32160,525 USD |
37,169 -14.8% | 4.32 | 160,525 USD | |
2020-01-10 | 2020-01-07 |
Idera Pharmaceuticals Inc
(IDRA)
|
S Sale |
3,006
-3.4%
1.785,352 USD |
3,006 -3.4% | 1.78 | 5,352 USD |